首页> 美国卫生研究院文献>Cardiovascular Ultrasound >Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report

【2h】

Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report

机译：长期使用不同PDE-5抑制剂治疗α干扰素诱发的肺动脉高压：一例报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

backgroundInterferon alpha2 is widely used in hepatitis and high-risk melanoma. Interferon-induced pulmonary arterial hypertension as a side effect is rare.

机译：背景干扰素α2广泛用于肝炎和高危黑色素瘤中。干扰素诱发的肺动脉高压很少见。

著录项

期刊名称 Cardiovascular Ultrasound
作者
Nicoline Jochmann; Felix Kiecker; Adrian C Borges; Maja A Hofmann; Stephan Eddicks; Wolfram Sterry; Gert Baumann; Uwe Trefzer;
展开▼
作者单位

展开▼
年(卷),期 2005(3),-1
年度 2005
页码 26
总页数 6
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
pulmonary arterial hypertension PAH PDE-5 inhibitor interferon-alpha;

机译：肺动脉高压;PAH;PDE-5抑制剂;α干扰素;
入库时间 2022-08-17 13:12:15

相似文献

外文文献
中文文献
专利

1. Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report [J] . Nicoline Jochmann, Felix Kiecker, Adrian C Borges, Cardiovascular Ultrasound . 2005,第1期

机译：长期使用不同PDE-5抑制剂治疗α干扰素诱发的肺动脉高压：一例报告
2. Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat [J] . David S. Poch BMC Pulmonary Medicine . 2016,第1期

机译：病例报告：肺动脉高压患者从PDE-5抑制剂转变为Riociguat
3. The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy [J] . Anastasia Anthi, Dimitrios Tsiapras, Panagiotis Karyofyllis, Pulmonary Circulation . 2021,第3期

机译：β-地中海贫血性血液诱导的肺动脉高压谱：两病例报告了特异性肺动脉高压治疗的可能作用
4. Hypoxia-Induced Proliferation Of Human Pulmonary Arterial Smooth Muscle Cells (Pasmc) Is Involved In The Suppression Of Cyclin-Dependent Kinase Inhibitors, P21, P27 And P53 [C] . T. Ishizaki, S. Mizuno, M. Kadowaki, NATO Advanced Research Workshop on Problems of High Altitude Medicine and Biology . 2007

机译：缺氧诱导的人肺动脉平滑肌细胞（PASMC）的增殖参与抑制细胞周期蛋白依赖性激酶抑制剂，P21，P27和P53
5. The lived experience: Pulmonary arterial hypertension and intravenous prostaglandin therapy [D] . Boone, Phyllis D. 2010

机译：生活经历：肺动脉高压和静脉注射前列腺素治疗
6. Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat [O] . David S. Poch 2016

机译：病例报告：肺动脉高压患者从PDE-5抑制剂转变为Riociguat
7. Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report [O] . Nicoline Jochmann, Felix Kiecker, Adrian C Borges, 2005

机译：长期使用不同PDE-5抑制剂治疗α干扰素诱发的肺动脉高压：一例报告

Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report

摘要

著录项

相似文献

相关主题

期刊订阅